Reports - Personalized Medicine Biomarkers Market
HealthcarePersonalized Medicine Biomarkers Market
Personalized Medicine Biomarkers Market Growth and Trends | Insights & Forecast 2025-2035 by Types (Liquid Biopsy, Others) by Applications (Oncology, Cardiology, Neurology, Immunology, Others
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Personalized Medicine Biomarkers Market - Segment Analysis
1. Overview
2. Global Personalized Medicine Biomarkers Market, 2021 - 2033 (USD Million)
3. Global Personalized Medicine Biomarkers Market - by Types
3.1. By Liquid Biopsy
3.2. By Others
4. Global Personalized Medicine Biomarkers Market - by Applications
4.1. By Oncology
4.2. By Cardiology
4.3. By Neurology
4.4. By Immunology
4.5. By Others
5. Global Personalized Medicine Biomarkers Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Personalized Medicine Biomarkers Market - Segment Analysis
1. Overview
2. North America Personalized Medicine Biomarkers Market, 2021 - 2033 (USD Million)
3. North America Personalized Medicine Biomarkers Market - by Types
3.1. By Liquid Biopsy
3.2. By Others
4. North America Personalized Medicine Biomarkers Market - by Applications
4.1. By Oncology
4.2. By Cardiology
4.3. By Neurology
4.4. By Immunology
4.5. By Others
Chapter 5 Europe Personalized Medicine Biomarkers Market - Segment Analysis
1. Overview
2. Europe Personalized Medicine Biomarkers Market, 2021 - 2033 (USD Million)
3. Europe Personalized Medicine Biomarkers Market - by Types
3.1. By Liquid Biopsy
3.2. By Others
4. Europe Personalized Medicine Biomarkers Market - by Applications
4.1. By Oncology
4.2. By Cardiology
4.3. By Neurology
4.4. By Immunology
4.5. By Others
Chapter 6 Asia Pacific Personalized Medicine Biomarkers Market - Segment Analysis
1. Overview
2. Asia Pacific Personalized Medicine Biomarkers Market, 2021 - 2033 (USD Million)
3. Asia Pacific Personalized Medicine Biomarkers Market - by Types
3.1. By Liquid Biopsy
3.2. By Others
4. Asia Pacific Personalized Medicine Biomarkers Market - by Applications
4.1. By Oncology
4.2. By Cardiology
4.3. By Neurology
4.4. By Immunology
4.5. By Others
Chapter 7 Latin America Personalized Medicine Biomarkers Market - Segment Analysis
1. Overview
2. Latin America Personalized Medicine Biomarkers Market, 2021 - 2033 (USD Million)
3. Latin America Personalized Medicine Biomarkers Market - by Types
3.1. By Liquid Biopsy
3.2. By Others
4. Latin America Personalized Medicine Biomarkers Market - by Applications
4.1. By Oncology
4.2. By Cardiology
4.3. By Neurology
4.4. By Immunology
4.5. By Others
Chapter 8 Middle East & Africa Personalized Medicine Biomarkers Market - Segment Analysis
1. Overview
2. Middle East & Africa Personalized Medicine Biomarkers Market, 2021 - 2033 (USD Million)
3. Middle East & Africa Personalized Medicine Biomarkers Market - by Types
3.1. By Liquid Biopsy
3.2. By Others
4. Middle East & Africa Personalized Medicine Biomarkers Market - by Applications
4.1. By Oncology
4.2. By Cardiology
4.3. By Neurology
4.4. By Immunology
4.5. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. GE Healthcare
2. Illumina Inc.
3. ASURAGEN Inc.
4. Danaher
5. bbott Laboratories
6. Exact Sciences Corporation
7. Biogen International
8. Exagen Inc.
9. Genelex Corporation
10. Precision Biologics Inc.
11. QIAGEN
12. IBM
13. Genentech Inc.
14. 23andME Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By